InvestSMART

Actinogen Medical Limited (ASX: ACW) - Announcements

Current share price for ACW : $0.063 0.006 (10.53%)+

ASX company news and announcements for Actinogen Medical Limited (ACW) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Actinogen Medical Limited (ACW) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Actinogen Medical Limited (ACW), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Actinogen Medical Limited (ACW)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$242 Notification of cessation of securities - ACW 16 Sep 2026 12:43PM $0.056 $0.063 risen by 12.50%
$242 Application for quotation of securities - ACW 15 Sep 2026 2:34PM $0.059 $0.063 risen by 6.78%
$242 Application for quotation of securities - ACW 11 Sep 2026 3:54PM $0.058 $0.063 risen by 8.62%
$242 Appendix 3Y-Dr Geoffrey Brooke 9 Sep 2026 12:54PM $0.061 $0.063 risen by 3.28%
$242 Application for quotation of securities - ACW 9 Sep 2026 12:40PM $0.061 $0.063 risen by 3.28%
$242 ACW CMO international Xanamem presentation 9 Sep 2026 10:11AM $0.064 $0.063 fallen by 1.56%
$242 Application for quotation of securities - ACW 8 Sep 2026 2:52PM $0.063 $0.063 fallen by 0%
$242 Application for quotation of securities - ACW 7 Sep 2026 4:39PM $0.059 $0.063 risen by 6.78%
$242 Response to ASX Price Query 4 Sep 2026 3:55PM $0.054 $0.063 risen by 16.67%
$242 Application for quotation of securities - ACW 3 Sep 2026 3:04PM $0.049 $0.063 risen by 28.57%
$242 Proposed issue of securities - ACW 1 Sep 2026 10:14AM $0.044 $0.063 risen by 43.18%
$242 ACW unlisted options fully underwritten 1 Sep 2026 10:12AM $0.044 $0.063 risen by 43.18%
$242 Application for quotation of securities - ACW 28 Aug 2026 3:58PM $0.043 $0.063 risen by 46.51%
$242 Appendix 3Y-Dr George Morstyn 28 Aug 2026 2:46PM $0.043 $0.063 risen by 48.24%
$242 Appendix 3Y-Dr Geoffrey Brooke 28 Aug 2026 2:43PM $0.043 $0.063 risen by 48.24%
$242 Application for quotation of securities - ACW 28 Aug 2026 2:36PM $0.043 $0.063 risen by 48.24%
$242 Appendix 4G 27 Aug 2026 4:42PM $0.042 $0.063 risen by 50%
$242 Corporate Governance Statement 27 Aug 2026 4:41PM $0.042 $0.063 risen by 50%
$242 ACW FY2026 results and outlook 27 Aug 2026 4:27PM $0.042 $0.063 risen by 50%
$242 ACW Appendix 4E and 2026 annual report 27 Aug 2026 4:26PM $0.042 $0.063 risen by 50%
$242 Appendix 3Y - Dr George Morstyn 20 Aug 2026 2:46PM $0.046 $0.063 risen by 38.46%
$242 Application for quotation of securities - ACW 20 Aug 2026 2:40PM $0.046 $0.063 risen by 38.46%
$242 Appendix 3Y-Malcolm McComas 17 Aug 2026 2:26PM $0.047 $0.063 risen by 35.48%
$242 Application for quotation of securities - ACW 17 Aug 2026 2:14PM $0.047 $0.063 risen by 35.48%
$242 ACW webinar today, The future of Alzheimers treatment 12 Aug 2026 9:14AM $0.047 $0.063 risen by 34.04%

1 - 25 of 906 results

Page 1 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.